A Revolutionary Kidney Stone Treatment
No Anesthesia. No Fluoroscopy.
Smarter and More Accessible
At Avvio Medical, we are transforming the standard of care for urinary stone disease with a cutting-edge, office-based procedure that reduces wait times and eliminates the need for fluoroscopy or general anesthesia.
Our innovative technology uses low-pressure ultrasound to activate calcium-seeking microbubbles, creating millions of micro-jets that break down stones. This approach aims to not only enhance patient safety and comfort but also lowers overall medical costs, offering a more accessible solution for stone removal.
Low-Pressure Cavitation Induced Fragmentation of Urinary Stone
Accelerated Timelapse of 5.6 minutes of actual treatment
Minimally Invasive
Our office-based procedure eliminates the need for general anesthesia or fluoroscopy, for a safer experience.
Faster Treatment
Shorter wait times streamline care, allowing for quicker stone removal and patient recovery.
Expanded Access
Procedures can be done in outpatient clinics or rural settings, reducing the need for specialized facilities.
Cost-Effective
The procedure reduces overall medical costs by avoiding expensive imaging and anesthesia.
See how it works
News & Events
See moreApplaud Medical Completes Series B Funding Round
October 28, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today confirmed that it had successfully raised an additional $7.1M in financing, led by Gudu Medical, for the company's Series B round. With this investment, the…Applaud Medical selected by MedTech Innovator as one of Top 50 Medtech Startups
June 15, 2021 | News
LOS ANGELES, CA – MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and Accelerator program, featuring the industry’s most transformative device, diagnostic, and…Applaud Medical Announces First Patient Enrolled in IDE Study
June 3, 2021 | News
SAN FRANCISCO--Applaud Medical, Inc. (Applaud), an emerging leader in the treatment of kidney stones, today announced announced enrollment of the first patient in the company's prospective, multicenter, randomized, double-blind AEROLITH (Acoustic Enhancer Research on Laser Lithotripsy) study. This U.S. Food…
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-006 Revision O, April 2025.